The AACC Academy is pleased to announce the winners of the 2018 Distinguished Abstracts Awards. A group of Fellows selected these 24 abstracts for their scientific excellence from a pool of 887 abstracts accepted for the 70th AACC Annual Scientific Meeting & Clinical Lab Expo.
Winning abstracts will display the Academy blue ribbon during the AACC Annual Scientific Meeting poster sessions in Chicago, Illinois.
A-100 Ibrahim Hashim, Dallas, TX
The implementation of the high sensitivity Troponin T (hs-TnT) generation five assay at a large teaching county hospital. A multi-speciality effort
A-103 Ian Gunsolus, Minneapolis, MN
Susceptibility of High Sensitivity Cardiac Troponin I and Gen 5 cTnT Assays to Biotin Interference
A-106 Ian Gunsolus, Minneapolis, MN
Baseline High-Sensitivity Cardiac Troponin I Aids in Risk Assessment in Patients with Diabetes, Hypertension, and Dyslipidemia without Myocardial Infarction
A-107 Karen Schulz, Minneapolis, MN
Sex-Specific 99th Percentiles Derived from the AACC Universal Sample Bank for 8 High-Sensitivity Cardiac Troponin Assays
A-211 Mark Kushnir, Salt Lake City, UT
Free 25 Hydroxy Vitamin D by LC-MS/MS: Reference Intervals in Healthy Adults and Observations in Pre-/Post-Menopausal Women
A-213 Hyosoon Park, Seoul, South Korea
Three alternative makers of hyperglycemia for early detection of diabetes: glycated albumin, 1,5-anhydroglucitol, and fructosamine
A-281 Dustin Bunch, New Haven, CT
Comparison of Multiple Analytical Approaches for Determining Reference Intervals
A-283 Heather Stieglitz, Chapel Hill, NC
Biotin interference in 21 immunoassays performed on the Vitros5600
A-321 Jamie Ashby, Birmingham, United Kingdom
QIP-MS: A specific, sensitive, accurate, and quantitative alternative to electrophoresis for the identification of intact monoclonal immunoglobulins
A-328 David Barnidge, Rochester, MN
Using QIP-MS to distinguish a therapeutic mAb from an endogenous M-protein in patients being treated for multiple myeloma
B-039 Ron Schifman, Tucson, AZ
Automated Laboratory-based Population Health System for Hepatitis C Birth Cohort Screening
B-041 Christopher McCudden, Ottawa, ON, Canada
A non-parametric quantile regression method to establish continuous reference intervals
B-117 Chiung-Guei Huang, Taoyuan, Taiwan
Transcriptome Differences in Normal Human Bronchial Epithelial Cells in Response to Influenza A pdmH1N1 or H7N9 Virus Infection
B-253 Yu Zhou, Cleveland, OH
An LC-MS/MS assay with online extraction for measurement of testosterone in serum or plasma
B-254 Lidong He, Tallahassee, FL
De Novo Amino Acid Sequencing of M-proteins by 21 Tesla FT-ICR MS Using Top-Down and Middle-Down MS/MS Techniques
B-256 Danni Li, Minneapolis, MN
Association of Plasma Metabolites with Brain MRI Measures in the Atherosclerosis Risk in Communities-Neurocognitive Study (ARIC-NCS)
B-307 Uttam Garg, Kansas City, MO
Significant Loss of Blood Amino Acids and Free Carnitine in Newborns Receiving Continuous Renal Replacement Therapy (CRRT)
B-327 Victoria Higgins, Toronto, ON, Canada
CALIPER continuous reference curves for biochemical markers: Advantages over traditional partitioned reference intervals
B-354 Martha Lyon, Saskatoon, SK, Canada
A novel tool to relate glucose meter performance to clinical outcome: The Insulin Dose Error Assessment (IDEA) Grid
B-355 Isabel Rodriguez Martin, Sevilla, Spain
Evaluation of health outcomes after the implementation of rotational thromboelastometry in patients undergoing cardiac surgery.
B-361 Ambalika Tanak, Richardson, TX
Electrochemical detection of Parathyroid hormone as a point-of-care testing device towards clinical applications
B-434 Youli Lu , Shanghai, China
A Liquid Chromatography Tandem Mass Spectrometry method for the Simultaneous Screening and Quantification of 10 Analgesics and Narcotics from Micro Plasma Collection Card
B-437 Adam Ptolemy, London, ON, Canada
Prevalence and Trends in Drug Use: Urine Drug Screening Positivity Rates for Community-based Patients in Ontario, Canada from 2014 to 2017
B-493 C. Taylor, Crumlin, United Kingdom
Application of a Biochip Array to Simultaneously Measure Analytes Related to Metabolic Syndrome in Serum with the Use of the New Random Access, Fully Automated Evidence Evolution Analyser